NYLIM U.S. Large Cap R&D Leaders ETF (NASDAQ:LRND – Get Free Report) was the recipient of a large decline in short interest in October. As of October 30th, there was short interest totaling 1,850 shares, a decline of 42.7% from the October 15th total of 3,226 shares. Based on an average daily trading volume, of 754 shares, the short-interest ratio is currently 2.5 days. Approximately 0.0% of the company’s stock are sold short.
NYLIM U.S. Large Cap R&D Leaders ETF Stock Performance
Shares of NYLIM U.S. Large Cap R&D Leaders ETF stock traded down $0.40 during trading on Tuesday, hitting $42.38. The company’s stock had a trading volume of 446 shares, compared to its average volume of 45,830. The company has a fifty day simple moving average of $46.52 and a two-hundred day simple moving average of $43.61. The company has a market capitalization of $410.24 million, a PE ratio of 25.67 and a beta of 1.11. NYLIM U.S. Large Cap R&D Leaders ETF has a 52 week low of $35.87 and a 52 week high of $49.31.
NYLIM U.S. Large Cap R&D Leaders ETF Cuts Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 2nd. Shareholders of record on Wednesday, September 30th were issued a $0.0439 dividend. This represents a $0.18 dividend on an annualized basis and a yield of 0.4%. This is a drop from NYLIM U.S. Large Cap R&D Leaders ETF’s previous quarterly dividend of $0.0456. The ex-dividend date was Wednesday, September 30th.
Hedge Funds Weigh In On NYLIM U.S. Large Cap R&D Leaders ETF
A hedge fund recently bought a new stake in NYLIM U.S. Large Cap R&D Leaders ETF stock. New York Life Investment Management LLC purchased a new position in NYLIM U.S. Large Cap R&D Leaders ETF (NASDAQ:LRND – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 9,463,171 shares of the company’s stock, valued at approximately $452,368,000. NYLIM U.S. Large Cap R&D Leaders ETF makes up about 3.1% of New York Life Investment Management LLC’s investment portfolio, making the stock its 4th biggest holding. New York Life Investment Management LLC owned about 100.35% of NYLIM U.S. Large Cap R&D Leaders ETF as of its most recent filing with the SEC.
About NYLIM U.S. Large Cap R&D Leaders ETF
The IQ U.S. Large Cap R&D Leaders ETF (LRND) is an exchange-traded fund that is based on the IQ U.S. Large Cap R&D Leaders index. The fund tracks an index of 100 large-cap US companies selected and weighted based on the most recently reported one year research and development (R&D) spending. LRND was launched on Feb 8, 2022 and is managed by IndexIQ.
See Also
- Five stocks we like better than NYLIM U.S. Large Cap R&D Leaders ETF
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for NYLIM U.S. Large Cap R&D Leaders ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NYLIM U.S. Large Cap R&D Leaders ETF and related companies with MarketBeat.com's FREE daily email newsletter.
